Trump and FDA Misrepresent Data as They Tout Blood Plasma Treatment - EcoWatch.com | Backstabber Watch | Scoop.it
From www.ecowatch.com - August 25, 2020 8:03 AM
In a news conference on Sunday, President Trump alongside Stephen Hahn, the head of the Food and Drug Administration (FDA), and Alex Azar, the secretary for Health and Human Services (HHS), touted the efficacy of blood plasma in treating COVID-19 as they announced its approval for a treatment.